Pharmaceutical

Japan approves updated Covid-19 vaccine to tackle JN.1 variant

Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination campaign.

Sep 14, 2024 - 04:00
Japan approves updated Covid-19 vaccine to tackle JN.1 variant
Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination campaign.
Read the original article

Tags:

Previous Article

Tern’s oral GLP-1 achieves 5% weight reduction within one month at the highest dose

Next Article

Oncternal stock crashes by 60% as it lays off staff and scraps trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Current large language models will not fix health care. Here’s what could

Opinion: Current large language models will not fix hea...

Aug 25, 2023

Virtual clinical trials: How digital tech has improved clinical trial accrual rates

Virtual clinical trials: How digital tech has improved ...

May 18, 2023

Specialty Pharmacies for the Pharmaceutical Industry

Specialty Pharmacies for the Pharmaceutical Industry

Oct 2, 2024